Chen R, Ding L, Liu Y, Shi J, Yu J, Li C
Mar Drugs. 2024; 22(10).
PMID: 39452867
PMC: 11509616.
DOI: 10.3390/md22100459.
Dwyer S, Ruth J, Seidel H, Raz A, Chodosh L
Breast Cancer Res. 2024; 26(1):143.
PMID: 39425240
PMC: 11488247.
DOI: 10.1186/s13058-024-01878-7.
Ryu K, Lee K, Park S, Kim T, Hong K, Kim H
Mol Cancer. 2024; 23(1):227.
PMID: 39390584
PMC: 11468019.
DOI: 10.1186/s12943-024-02138-0.
Situm ceprnja Z, Kelam N, Ogorevc M, Racetin A, Vukoja M, ceprnja T
Cells. 2024; 13(17.
PMID: 39273022
PMC: 11394338.
DOI: 10.3390/cells13171450.
MacFawn I, Farris J, Pifer P, Margaryan N, Akhter H, Wang L
Mol Immunol. 2024; 170:156-169.
PMID: 38692097
PMC: 11106721.
DOI: 10.1016/j.molimm.2024.04.012.
The TGFβ2-Snail1-miRNA Circuitry is Critical for the Development of Aggressive Functions in Breast Cancer.
Luo L, Xu N, Fan W, Wu Y, Chen P, Li Z
Clin Transl Med. 2024; 14(2):e1558.
PMID: 38299307
PMC: 10831563.
DOI: 10.1002/ctm2.1558.
Biology of Pellino1: a potential therapeutic target for inflammation in diseases and cancers.
Yan L, Cui Y, Feng J
Front Immunol. 2024; 14:1292022.
PMID: 38179042
PMC: 10765590.
DOI: 10.3389/fimmu.2023.1292022.
USP30 promotes the progression of breast cancer by stabilising Snail.
Sun K, Liao S, Yao X, Yao F
Cancer Gene Ther. 2023; 31(3):472-483.
PMID: 38146008
PMC: 10940155.
DOI: 10.1038/s41417-023-00718-8.
Expression of Tumor Suppressor Is Regulated by the -SNAIL Axis in Human Lung Adenocarcinoma.
Suzuki T, Sakai S, Ota K, Yoshida M, Uchida C, Niida H
Int J Mol Sci. 2023; 24(23).
PMID: 38069335
PMC: 10707390.
DOI: 10.3390/ijms242317011.
B3GALT6 promotes dormant breast cancer cell survival and recurrence by enabling heparan sulfate-mediated FGF signaling.
Sreekumar A, Lu M, Choudhury B, Pan T, Pant D, Lawrence-Paul M
Cancer Cell. 2023; 42(1):52-69.e7.
PMID: 38065100
PMC: 10872305.
DOI: 10.1016/j.ccell.2023.11.008.
PCSK9 promotes tumor cell proliferation and migration by facilitating CCL25 secretion in esophageal squamous cell carcinoma.
Wang H, Guo Q, Wang M, Liu C, Tian Z
Oncol Lett. 2023; 26(5):500.
PMID: 37854863
PMC: 10579978.
DOI: 10.3892/ol.2023.14086.
The Triple Crown: NO, CO, and HS in cancer cell biology.
Oza P, Kashfi K
Pharmacol Ther. 2023; 249:108502.
PMID: 37517510
PMC: 10529678.
DOI: 10.1016/j.pharmthera.2023.108502.
The Landscape of Small Leucine-Rich Proteoglycan Impact on Cancer Pathogenesis with a Focus on Biglycan and Lumican.
Berdiaki A, Giatagana E, Tzanakakis G, Nikitovic D
Cancers (Basel). 2023; 15(14).
PMID: 37509212
PMC: 10377491.
DOI: 10.3390/cancers15143549.
Predictive value of machine learning for breast cancer recurrence: a systematic review and meta-analysis.
Lu D, Long X, Fu W, Liu B, Zhou X, Sun S
J Cancer Res Clin Oncol. 2023; 149(12):10659-10674.
PMID: 37302114
DOI: 10.1007/s00432-023-04967-w.
Snail inhibits metastasis via regulation of E‑cadherin and is associated with prognosis in colorectal cancer.
Wang W, Jin J, Zhou Z, Wang Y, Min K, Zuo X
Oncol Lett. 2023; 25(6):271.
PMID: 37216162
PMC: 10193364.
DOI: 10.3892/ol.2023.13857.
Pro- and anti-tumour activities of CD146/MCAM in breast cancer result from its heterogeneous expression and association with epithelial to mesenchymal transition.
Mannion A, Odell A, Baker S, Matthews L, Jones P, Cook G
Front Cell Dev Biol. 2023; 11:1129015.
PMID: 37138793
PMC: 10150653.
DOI: 10.3389/fcell.2023.1129015.
Dormancy in Breast Cancer.
Dalla E, Sreekumar A, Aguirre-Ghiso J, Chodosh L
Cold Spring Harb Perspect Med. 2023; 13(11.
PMID: 37037598
PMC: 10562521.
DOI: 10.1101/cshperspect.a041331.
Epithelial-to-Mesenchymal Transition and Phenotypic Marker Evaluation in Human, Canine, and Feline Mammary Gland Tumors.
Sammarco A, Gomiero C, Beffagna G, Cavicchioli L, Ferro S, Michieletto S
Animals (Basel). 2023; 13(5).
PMID: 36899736
PMC: 10000046.
DOI: 10.3390/ani13050878.
Non-canonical functions of SNAIL drive context-specific cancer progression.
Paul M, Schneeweis C, Falcomata C, Shan C, Rossmeisl D, Koutsouli S
Nat Commun. 2023; 14(1):1201.
PMID: 36882420
PMC: 9992512.
DOI: 10.1038/s41467-023-36505-0.
Implications of Axis Inhibition Protein 2 in Breast Cancer Progression.
Ahn S, Jo C
In Vivo. 2023; 37(2):634-643.
PMID: 36881079
PMC: 10026660.
DOI: 10.21873/invivo.13122.